XML 62 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Accounting Changes (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure Of Voluntary Change In Accounting Policy [Abstract]  
Summary of Impact on Changes in Accounting Policy There is no impact of this policy change on gross profit, net income (loss), basic and diluted earnings per share, the consolidated statement of financial position, or the consolidated the statement of changes in equity on the current or any prior period, upon retrospective application.

 

 

2018

 

 

2017

 

 

Original

accounting

policy

 

 

New

accounting

policy

 

 

Original

accounting

policy

 

 

New

accounting

policy

 

Consolidated statement of operations and comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales before fair value adjustments

$

2,942

 

 

$

7,654

 

 

$

609

 

 

$

2,040

 

Production costs

 

7,145

 

 

 

-

 

 

 

3,983

 

 

 

-

 

Total cost of sales

 

10,087

 

 

 

7,654

 

 

 

4,592

 

 

 

2,040

 

Gross profit (loss) before fair value adjustments

 

5,616

 

 

 

8,049

 

 

 

(510

)

 

 

2,042

 

Fair value adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized change in fair value of biological assets

 

(18,713

)

 

 

(11,568

)

 

 

(11,620

)

 

 

(7,637

)

Realized fair value adjustments on inventory sold in the year

 

13,061

 

 

 

8,349

 

 

 

3,880

 

 

 

2,449

 

Total fair value adjustments

 

(5,652

)

 

 

(3,219

)

 

 

(7,740

)

 

 

(5,188

)

Gross profit

$

11,268

 

 

$

11,268

 

 

$

7,230

 

 

$

7,230

 

 

 

 

2018

 

 

2017

 

 

Original

accounting

policy

 

 

New

accounting

policy

 

 

Original

accounting

policy

 

 

New

accounting

policy

 

Consolidated statement of cash flows

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Items not affecting cash:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized change in fair value of biological assets

$

(18,713

)

 

$

(11,568

)

 

$

(11,620

)

 

$

(7,637

)

Realized fair value adjustments on inventory sold in the year

 

13,061

 

 

 

8,349

 

 

 

3,880

 

 

 

2,449

 

Net changes in non-cash working capital:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Biological assets

 

13,361

 

 

 

6,216

 

 

 

9,693

 

 

 

5,710

 

Inventory

 

(16,229

)

 

 

(11,517

)

 

 

(10,388

)

 

 

(8,957

)

Net effect on cash flows used in operating activities

$

(8,520

)

 

$

(8,520

)

 

$

(8,435

)

 

$

(8,435

)